[{"type": "title", "data": "=Attributes!B2"}, {"type": "category", "data": "Patient Care"}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Refer to latest BC CDC \u2013 COVID-19 Therapeutics Committee Guidelines for most up-to-date criteria", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Insert Peripheral IV (Intravenous) Catheter\u00a0 ", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "once, prior to sotrovimab infusion"}, {"type": "category", "data": "Medications"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, pre-procedure, drug form: cap"}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "650 mg, PO, pre-procedure, drug form: tab"}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "sotrovimab", "value": "checked"}, {"type": "sentence", "data": "500 mg IV, once, drug form inj"}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Select or modify the medications within Hypersensitivity/ Anaphylaxis Treatment Module as required", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "subphase/module", "data": "Hypersensitivity/ Anaphylaxis Treatment (Module)", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}]
